Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phrenic Nerve Block for Chronic Neck Pain (PAINOMICS)
NCT05605639Phase 4Recruiting
- Sponsor
- University of Seville
- Start
- Nov 2022
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in Chronic neck pain (2 arms), sponsored by University of Seville. Primary endpoint: Change from baseline in algometry (Pressure Pain Threshold) at 7 days. Started Nov 2022; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
Chronic neck pain
Beyond the preview
Go deeper on NCT05605639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05605639.